Table.
Characteristic | Survey Respondents (n = 336), % |
National Primary Care Physician Population, %* |
---|---|---|
Specialty | ||
Family practice | 52.4 | 51.5 |
General practice | 4.5 | 3.6 |
Internal medicine | 43.2 | 44.9 |
Age | ||
<35 y | 7.6 | 5.7 |
35-44 y | 19.1 | 22.6 |
45-54 y | 29.4 | 30.7 |
55-64 y | 28.5 | 27.3 |
≥65 y | 15.5 | 13.7 |
Sex | ||
Female | 41.2 | 39.1 |
Male | 58.8 | 60.9 |
Region | ||
Northeast | 22.1 | 19.0 |
South | 29.8 | 35.6 |
Midwest | 22.1 | 20.9 |
West | 26.1 | 24.6 |
Practice type† | ||
Solo or 2-physician | 17.5 | Not available |
Group | 50.9 | Not available |
Nongovernmental hospital | 4.6 | Not available |
Government-based | 11.4 | Not available |
Other‡ | 15.6 | Not available |
Buprenorphine waivers§ | ||
Physicians with X waiver | 10.6 | Not available |
Mean estimated percentage of patients in panel with OUD | 7.1 | Not available |
OUD = opioid use disorder.
From reference 2.
National data on practice type among primary care physicians defined as family, internal, or general medicine physicians are not available.
Includes other patient care, locum tenens, and no classification.
In 2019, an estimated 8.3% of all U.S. physicians had a buprenorphine waiver. Data on the proportion of primary care physicians with a waiver nationally are not available (www.samhsa.gov/medication-assisted-treatment/practitioner-program-data/certified-practitioners).